Related Experiment Videos
[Relapsing epistaxis: embolization as treatment of choice]
1Divisione di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Ospedale Niguarda-Ca Granda Milano.
Summary
Therapeutic embolization effectively controls severe epistaxis (nosebleeds), especially in patients with essential or hereditary hemorrhagic conditions. This minimally invasive procedure offers a safe and rapid alternative to traditional treatments like arterial ligation.
Area of Science:
- Otolaryngology
- Interventional Radiology
- Vascular Surgery
Background:
- Epistaxis (nosebleeds) is common, with severe posterior cases often requiring hospitalization.
- Traditional treatments like nasal packing and arterial ligation have limitations, including potential failure and surgical complexity.
- Arterial ligation, while an alternative, faces challenges due to anatomical variations and potential anastomoses.
Purpose of the Study:
- To evaluate the efficacy and safety of therapeutic embolization for managing recurrent and severe epistaxis.
- To compare outcomes in patients with essential epistaxis versus those with underlying systemic diseases.
Main Methods:
- Fifteen patients with recurrent nasal bleeding underwent embolization using Polyvinyl Alcohol (PVA) particles.
- Patients included those with essential epistaxis and those with conditions like hereditary hemorrhagic telangiectasia and angiomas.
- Outcomes were assessed based on bleeding control following the procedure.
Main Results:
- Therapeutic embolization achieved good bleeding control in 90% of patients with essential epistaxis after one procedure.
- Satisfactory bleeding control was observed in patients with hereditary hemorrhagic telangiectasia.
- The procedure demonstrated efficacy and safety in managing complex epistaxis cases.
Conclusions:
- Therapeutic embolization with PVA particles is a highly effective treatment for recurrent persistent epistaxis.
- Its efficacy, speed, and safety profile make it a preferred option over traditional methods.
- Embolization offers a viable solution for challenging epistaxis cases unresponsive to other treatments.